Literature DB >> 30502287

Impact of New-Onset Postoperative Depression on Readmission Outcomes After Surgical Coronary Revascularization.

Esteban Aguayo1, Robert Lyons2, Yen-Yi Juo2, Katherine L Bailey1, Young-Ji Seo1, Vishal Dobaria2, Yas Sanaiha2, Peyman Benharash3.   

Abstract

BACKGROUND: Depression affects between 10% and 40% of cardiac surgery patients and is associated with significantly worse outcomes. The incidence and impact of new-onset depression beyond acute follow-up remain ill-defined. The present study aimed to evaluate the incidence, risk factors, and prognostic implication of depression on 90-d readmission rates after coronary artery bypass grafting (CABG) surgery.
METHODS: A retrospective cohort study was performed identifying adult patients without prior depression who underwent CABG surgery using the 2010-2014 National Readmissions Database. CABG patients who were readmitted more than 2 wk but within 90 d of discharge were categorized based on the presence of new-onset depression. Association between the development of new-onset depression and rehospitalization were morbidity, mortality, costs, and length of stay (LOS) and were examined using multivariable regression.
RESULTS: During the study period, 1,001,945 patients underwent CABG. Of these, 11.7% of patients were readmitted after 14 d but within 90 d of discharge with 5.1% of these patients having a diagnosis of new-onset depression. Postoperative new-onset depression was not associated with increased readmission morbidity, costs, or LOS. Mortality in new-onset depression readmissions was 1.2%, compared with 2.3% in all readmitted patients (P = 0.014). Depression was associated with lower odds of mortality (OR = 0.56, P = 0.02).
CONCLUSIONS: New-onset depression following CABG discharge was not associated with increased odds of mortality, morbidity, costs, or increased LOS on readmission. Rather, new-onset depression is associated with decreased odds of readmission mortality. Overall, CABG readmissions are decreasing, whereas the rate of new-onset depression is slightly increasing. Implementation of routine depression screening tools in postoperative CABG care may aid in early detection and management of depression to enhance postoperative recovery and quality of life.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CABG; Cardiac surgery; Coronary artery bypass graft surgery; Depression; National readmissions database; Postoperative depression

Mesh:

Year:  2018        PMID: 30502287     DOI: 10.1016/j.jss.2018.07.062

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  4 in total

Review 1.  A Narrative Review of the Association Between Depression and Heart Disease Among Women: Prevalence, Mechanisms of Action, and Treatment.

Authors:  Danielle Rome; Alyssa Sales; Rebecca Leeds; John Usseglio; Talea Cornelius; Catherine Monk; Kim G Smolderen; Nathalie Moise
Journal:  Curr Atheroscler Rep       Date:  2022-06-25       Impact factor: 5.967

2.  Risk of depression after coronary artery bypass grafting: a SWEDEHEART population-based cohort study.

Authors:  Malin Stenman; Anders Jeppsson; Aldina Pivodic; Ulrik Sartipy; Susanne J Nielsen
Journal:  Eur Heart J Open       Date:  2022-03-02

3.  H-FABP Levels and Psycho-Emotional Improvement of CABG Patients during Cardiac Rehabilitation.

Authors:  Razan Al Namat; Dina Al Namat; Manuela Ciocoiu; Marius Valeriu Hînganu; Laurențiu Șorodoc; Victorița Șorodoc; Liliana Georgeta Foia; Laura Florea; Cristiana Vlad; Ana Tănasă; Mihai Constantin; Daniel Cioloca; Minerva Codruța Bădescu; Amin Bazyani; Maura Felea
Journal:  J Cardiovasc Dev Dis       Date:  2022-07-28

4.  The Effect of Rhythmic Breathing on the Severity of Sternotomy Pain after Coronary Artery Bypass Graft Surgery: A Randomized Controlled Clinical Trial.

Authors:  Hassan Babamohamadi; Masoumeh Karkeabadi; Abbasali Ebrahimian
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-10       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.